SMA UK’s submission to NICE’s scoping consultation on AVXS-101 treatment for infants with SMA Type 1

17 October 2018

England’s regulatory body, the National Institute of Care and Health Excellence (NICE), has invited a wide range of clinical and patient groups to comment on this treatment. You can read what we have said to NICE here, and more about the NICE process here